In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

H. Lundbeck A/S

http://www.lundbeck.com

Latest From H. Lundbeck A/S

Lundbeck Pursues Brintellix Infringement Charges In India

Lundbeck seeks to ward off Alembic and Hetero over alleged patent infringing activity pertaining to its depression therapy vortioxetine in India. The product is seen as one of the key drivers of growth in 2021 for the Danish company, which has settled infringement proceedings with over half a dozen generic opponents so far in the US.

Commercial Intellectual Property

Analyst Insight: Top 2021 Health Care Trends On Display At RSNA

A confluence of factors promoting the rapid adoption of health care AI is expected to make 2021 a pivotal year for the technology, as demonstrated by product launches at RSNA 2020.

Trends Artificial Intelligence

Asia Deal Watch: Kyongbo To Supply Ceftobiprole API For Basilea

Plus deals involving Helixmith/Wacker, Sosei Heptares/Metrion, Ono/Ribon, Asahi Kasei/Lilly, Citrine/Diurnal, Mitsubishi Tanabe/Aquestive, Immunotech/T-Cure, TRIGR/Elpiscience, Daiichi Sankyo/ViGeneron

Deals Business Strategies

Lundbeck Highlights Vyepti Potential, But Company's 2021 Outlook Cautious

Lundbeck is focused on the global launch of its new migraine therapy Vyepti in the coming years, and the development of additional indications, as its reported a 4% increase in revenues in 2020 which were within its pre-pandemic guidance.

Sales & Earnings Neurology
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Abide Therapeutics Inc.
    • Alder Biopharmaceuticals, Inc.
    • Chelsea Therapeutics International, Ltd.
    • Lundbeck La Jolla Research Center
    • Lundbeck Seattle Biopharmaceuticals
    • Ovation Pharmaceuticals, Inc
    • Saegis Pharmaceuticals, Inc.
UsernamePublicRestriction

Register